243 related articles for article (PubMed ID: 1067811)
1. Outpatient screening tests for primary aldosteronism.
Dunn PJ; Espiner EA
Aust N Z J Med; 1976 Apr; 6(2):131-5. PubMed ID: 1067811
[TBL] [Abstract][Full Text] [Related]
2. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
[No Abstract] [Full Text] [Related]
3. Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans.
Olivieri O; Castagna A; Guarini P; Chiecchi L; Sabaini G; Pizzolo F; Corrocher R; Righetti PG
Hypertension; 2005 Oct; 46(4):683-8. PubMed ID: 16172430
[TBL] [Abstract][Full Text] [Related]
4. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Schwartz GL; Turner ST
Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
[TBL] [Abstract][Full Text] [Related]
5. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
6. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
Zadik Z; Levin PA; Hamilton BP; Kowarski AA
Hypertension; 1986 Apr; 8(4):285-9. PubMed ID: 3514448
[TBL] [Abstract][Full Text] [Related]
7. Laboratory challenges in primary aldosteronism screening and diagnosis.
Rehan M; Raizman JE; Cavalier E; Don-Wauchope AC; Holmes DT
Clin Biochem; 2015 Apr; 48(6):377-87. PubMed ID: 25619896
[TBL] [Abstract][Full Text] [Related]
8. Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism.
Pizzolo F; Chiecchi L; Morandini F; Castagna A; Zorzi F; Zaltron C; Pattini P; Chiariello C; Salvagno G; Olivieri O
J Hypertens; 2017 Feb; 35(2):355-361. PubMed ID: 27841781
[TBL] [Abstract][Full Text] [Related]
9. Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system.
Sivarajah M; Beninato T; Fahey TJ
Surgery; 2020 Jan; 167(1):211-215. PubMed ID: 31564486
[TBL] [Abstract][Full Text] [Related]
10. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.
Abdelhamid S; Blomer R; Hommel G; Haack D; Lewicka S; Fiegel P; Krumme B
Am J Hypertens; 2003 Jul; 16(7):522-30. PubMed ID: 12850384
[TBL] [Abstract][Full Text] [Related]
11. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
[TBL] [Abstract][Full Text] [Related]
12. Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
Lund JO; Nielsen MD
Acta Endocrinol (Copenh); 1980 Jan; 93(1):100-7. PubMed ID: 6986736
[TBL] [Abstract][Full Text] [Related]
13. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
14. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
[TBL] [Abstract][Full Text] [Related]
15. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of the 24 hour integrated concentration of plasma aldosterone.
Zadik Z; Levin P; Kowarski A
Clin Exp Hypertens A; 1985; 7(9):1233-42. PubMed ID: 3907895
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
[TBL] [Abstract][Full Text] [Related]
18. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
[TBL] [Abstract][Full Text] [Related]
19. [The aldosterone to Renin ratio in secondary hypertension].
Seiler L; Reincke M
Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
